Pablo Lapuerta

Pablo Lapuerta

Fondatore presso 4m Therapeutics, Inc.

60 anni
Consumer Services
Health Technology

Profilo

Pablo Lapuerta is the founder of 4M Therapeutics, Inc. He previously worked as an Executive Director-Global Medical Affairs at Bristol Myers Squibb Co. from 2009 to 2010.
From 2011 to 2020, he served as the Chief Medical Officer & Executive Vice President at Lexicon Pharmaceuticals, Inc. Prior to that, he was the Chief Medical Officer & SVP-Clinical Strategy at Cogentus Pharmaceuticals, Inc. from 2007 to 2009.
Additionally, he held positions as a Principal at the University of Southern California and Robert Wood Johnson Medical School.
Dr. Lapuerta obtained his doctorate degree from Harvard Medical School and his undergraduate degree from Harvard College.

Posizioni attive di Pablo Lapuerta

SocietàPosizioneInizio
4m Therapeutics, Inc. Fondatore -
Tutte le posizioni attive di Pablo Lapuerta

Precedenti posizioni note di Pablo Lapuerta

SocietàPosizioneFine
LEXICON PHARMACEUTICALS, INC. Direttore Tecnico/Scientifico/R&S 30/09/2020
BRISTOL-MYERS SQUIBB COMPANY Direttore Tecnico/Scientifico/R&S -
Direttore Tecnico/Scientifico/R&S -
Corporate Officer/Principal -
Robert Wood Johnson Medical School Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Pablo Lapuerta

Formazione di Pablo Lapuerta

Harvard Medical School Doctorate Degree
Harvard College Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Pablo Lapuerta

Relazioni

35

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

LEXICON PHARMACEUTICALS, INC.

Health Technology

Aziende private2

Health Technology

4m Therapeutics, Inc.

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Pablo Lapuerta
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA